Variant report
Variant | nsv972244 |
---|---|
Chromosome Location | chr8:110389671-110400955 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:15)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:15 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:110399100..110401680-chr8:110403337..110405156,2 | K562 | blood: | |
2 | chr8:110399789..110401948-chr8:110406839..110408656,2 | K562 | blood: | |
3 | chr8:110399789..110401392-chr8:110406709..110408339,2 | K562 | blood: | |
4 | chr8:110388617..110395072-chr8:110396032..110405839,11 | K562 | blood: | |
5 | chr8:110388617..110395072-chr8:110396032..110405839,11 | K562 | blood: | |
6 | chr8:110397376..110399556-chr8:110407254..110410081,2 | K562 | blood: | |
7 | chr8:110397373..110399828-chr8:110505690..110508375,2 | K562 | blood: | |
8 | chr8:110373158..110374661-chr8:110392938..110394946,2 | MCF-7 | breast: | |
9 | chr8:110397526..110401680-chr8:110402055..110405525,5 | K562 | blood: | |
10 | chr8:110376237..110378577-chr8:110400092..110402254,2 | K562 | blood: | |
11 | chr8:110391499..110394340-chr8:110396610..110400316,3 | K562 | blood: | |
12 | chr8:110396038..110397766-chr8:110402101..110404529,2 | K562 | blood: | |
13 | chr8:110391499..110394340-chr8:110396610..110400316,3 | K562 | blood: | |
14 | chr8:110374002..110377737-chr8:110399223..110401592,3 | K562 | blood: | |
15 | chr8:110392136..110393759-chr8:110551713..110554181,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000147654 | chromatin interactions |
ENSG00000205038 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186777934 | chr8:110390410-110390411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150886569 | chr8:110390435-110390436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs139301606 | chr8:110390447-110390448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558949293 | chr8:110390450-110390451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569564102 | chr8:110390734-110390735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191537521 | chr8:110390739-110390740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184103719 | chr8:110390793-110390794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs574987140 | chr8:110390826-110390827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs113798295 | chr8:110390858-110390859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554250103 | chr8:110390877-110390878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572918612 | chr8:110390970-110390971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs79754675 | chr8:110390999-110391000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574973227 | chr8:110391006-110391007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116480360 | chr8:110391007-110391008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575189295 | chr8:110391058-110391059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs2349436 | chr8:110391080-110391081 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs560595753 | chr8:110391081-110391082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146577803 | chr8:110391094-110391095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs546245385 | chr8:110391095-110391096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188568487 | chr8:110391097-110391098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs532566945 | chr8:110391130-110391131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs111460872 | chr8:110391142-110391143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577326746 | chr8:110391150-110391151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs181288607 | chr8:110391151-110391152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558261999 | chr8:110391175-110391176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs185016661 | chr8:110391178-110391179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567236111 | chr8:110391194-110391195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs190403815 | chr8:110391205-110391206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs568423740 | chr8:110391206-110391207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534201263 | chr8:110391222-110391223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs140003005 | chr8:110391244-110391245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577297066 | chr8:110391286-110391287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs78957349 | chr8:110391350-110391351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558755676 | chr8:110391362-110391363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs575179960 | chr8:110391371-110391372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs544051606 | chr8:110391419-110391420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs182103606 | chr8:110391438-110391439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs115284012 | chr8:110391476-110391477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540244257 | chr8:110391512-110391513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559978672 | chr8:110391514-110391515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532276502 | chr8:110391532-110391533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs79000318 | chr8:110391551-110391552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563027968 | chr8:110391587-110391588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143613219 | chr8:110391592-110391593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs116790458 | chr8:110392275-110392276 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs561969717 | chr8:110392297-110392298 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs1457293 | chr8:110392318-110392319 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs576769119 | chr8:110392338-110392339 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs543915207 | chr8:110392379-110392380 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs546827681 | chr8:110392380-110392381 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Gastric cancer | 22539939 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Oral squamous cell carcinoma | 21853135 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
Prostate cancer | 22341455 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:110390400-110391600 | Enhancers | K562 | blood |
2 | chr8:110393200-110393600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr8:110398200-110398600 | Enhancers | K562 | blood |
4 | chr8:110398600-110401400 | Weak transcription | K562 | blood |
5 | chr8:110399400-110400000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr8:110399800-110400400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
7 | chr8:110400000-110400200 | Bivalent Enhancer | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |